HEXO Corp. Operating Income 2011-2025 | HEXO

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income HEXO Corp.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-85.5 M	-477 M	-84.6 M	-18 M	-	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
-18 M	-477 M	-166 M

Operating Income of other stocks in the Drug manufacturers industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Canopy Growth Corporation CGC	-117 M	$ 1.68	-3.44 %	$ 181 M	Canada
Alimera Sciences ALIM	-1.93 M	-	-	$ 142 M	USA
Assertio Holdings ASRT	-244 M	$ 0.74	-3.53 %	$ 52.6 M	USA
Aerie Pharmaceuticals AERI	-46.4 M	-	-	$ 754 M	USA
AcelRx Pharmaceuticals ACRX	-15.3 M	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	-25.1 M	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	-19.9 M	-	10.11 %	$ 58.2 M	USA
Aurora Cannabis ACB	-283 M	$ 5.1	-5.59 %	$ 86.3 M	Canada
Catalent CTLT	-749 M	-	-	$ 11.5 B	USA
Calliditas Therapeutics AB (publ) CALT	-524 M	-	-0.1 %	$ 2.03 B	Schweden
DURECT Corporation DRRX	-36.9 M	-	-	$ 50.1 M	USA
Organogenesis Holdings ORGO	-1.28 M	$ 4.76	-1.14 %	$ 627 M	USA
Eagle Pharmaceuticals EGRX	81 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	-469 M	-	-	$ 28.9 M	Irlanda
Pacira BioSciences PCRX	-73.4 M	$ 26.64	1.33 %	$ 1.23 B	USA
Emergent BioSolutions EBS	-726 M	$ 12.27	7.44 %	$ 628 M	USA
Evoke Pharma EVOK	-7.43 M	$ 10.97	0.14 %	$ 36.7 M	USA
Athenex ATNX	-70 M	-	-23.39 %	$ 1.76 M	USA
Rockwell Medical RMTI	-6.67 M	$ 0.88	-5.2 %	$ 20.5 M	USA
Avadel Pharmaceuticals plc AVDL	-42.4 M	$ 21.43	0.3 %	$ 2.04 B	France
Sonoma Pharmaceuticals SNOA	-3.71 M	$ 3.52	-2.07 %	$ 4.37 M	USA
Evolus EOLS	-34.4 M	$ 7.14	1.42 %	$ 443 M	USA
Harrow Health HROW	431 K	$ 46.39	-1.43 %	$ 1.51 B	USA
China Pharma Holdings CPHI	-4.59 M	$ 1.53	-1.92 %	$ 26.7 M	China
Bausch Health Companies BHC	963 M	$ 6.87	-0.79 %	$ 2.51 B	Canada
Veru VERU	-36.9 M	$ 2.39	-1.24 %	$ 322 M	USA
Lannett Company LCI	-176 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	-91.8 M	$ 1.81	-5.99 %	$ 402 M	Canada
cbdMD YCBD	-3.32 M	$ 1.18	-3.28 %	$ 5.09 M	USA
Cumberland Pharmaceuticals CPIX	-1.84 M	$ 3.04	20.16 %	$ 42.7 M	USA
Neoleukin Therapeutics NLTX	-55.6 M	-	-	$ 193 M	Canada
Solid Biosciences SLDB	-130 M	$ 5.77	-1.79 %	$ 236 M	USA
PetIQ PETQ	37.1 M	-	1.64 %	$ 400 M	USA
Relmada Therapeutics RLMD	-104 M	$ 4.34	6.9 %	$ 131 M	USA
Perrigo Company plc PRGO	113 M	$ 12.77	-2.85 %	$ 1.75 B	USA
ProPhase Labs PRPH	23.6 M	$ 0.12	0.87 %	$ 1.9 M	USA
Radius Health RDUS	-54.3 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	-3.57 M	-	-4.76 %	$ 65.3 M	USA
Sundial Growers SNDL	-132 M	$ 1.96	-11.31 %	$ 3.37 M	Canada
OptiNose OPTN	-22.7 M	-	-	$ 1.08 B	USA
PLx Pharma PLXP	-40.8 M	-	-27.8 %	$ 2.56 M	USA
SCYNEXIS SCYX	72.7 M	$ 0.64	-0.91 %	$ 30.6 M	USA
Tricida TCDA	-153 M	-	-	$ 3.25 M	USA
Tilray TLRY	-1.37 B	$ 11.19	-7.9 %	$ 6.92 B	Canada
TherapeuticsMD TXMD	-8.52 M	$ 1.7	-2.86 %	$ 17.7 M	USA
Zomedica Corp. ZOM	-31.6 M	-	-0.21 %	$ 98 M	USA
Viatris VTRS	1.61 B	$ 11.65	-	$ 14.1 B	USA